Common CX3CR1 alleles are associated with a reduced risk of headaches. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Headache Année : 2008

Common CX3CR1 alleles are associated with a reduced risk of headaches.

Résumé

OBJECTIVES: The aim of this study was to investigate the role of the chemokine receptor CX3CR1 in headaches and migraine. METHODS: Distribution of 2 polymorphisms of the chemokine receptor CX3CR1 (V249I and T280M) was determined in a population-based sample of 1179 elderly individuals. RESULTS: Heterozygotes for both CX3CR1 polymorphisms had a reduced risk of recurrent headaches, with an odds ratio (OR) of 0.64 (95% confidence interval [CI] = 0.46-0.90) for the I249 allele and 0.55 (95% CI = 0.38-0.81) for the M280 allele. Haplotype analysis showed that carriers of the rarer CX3CR1 I249-M280 haplotype had a reduced risk of recurrent headaches, with an OR of 0.57 (95% CI = 0.41-0.80, P = .001). This association was seen for both nonmigraine headaches (OR = 0.47, 95% CI = 0.28-0.79, P = .004) and migraine (OR = 0.65, 95% CI = 0.43-0.98, P = .041). CONCLUSIONS: These results need to be replicated but suggest that the chemokine receptor CX3CR1 may play a role in recurrent headaches.
Fichier principal
Vignette du fichier
nvCombadiere_et_al_CTZ.pdf (246.69 Ko) Télécharger le fichier
Loading...

Dates et versions

inserm-00175880 , version 1 (23-06-2014)

Identifiants

Citer

Christophe Combadière, Ophelia Godin, Cécile Vidal, Arnaud Cangialosi, Carole Proust, et al.. Common CX3CR1 alleles are associated with a reduced risk of headaches.: CX3CR1 gene polymorphisms and headaches.. Headache, 2008, 48 (7), pp.1061-6. ⟨10.1111/j.1526-4610.2007.01011.x⟩. ⟨inserm-00175880⟩
146 Consultations
304 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More